ClinicalTrials.Veeva

Menu
D

DaVita Clinical Research | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bardoxolone Methyl
Clazakizumab
Selonsertib
SNF472
Pilocarpine
BI 685509

Parent organization

This site is a part of DaVita Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 7 total trials

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300

Trial sponsors

Boehringer Ingelheim logo
Biogen logo
CSL Behring logo
Gilead Sciences logo
Ocuphire Pharma logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems